Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Edenred SE (EDNMY) Q1 2026 Sales/Trading Call Transcript
Edenred is fundamentally sound, A-rated, and offers an 8.5% yield, despite recent share price declines. Current regulatory headwinds in Brazil, Italy, and France may reduce EBITDA, but do not threaten Edenred's core earnings or market leadership. EDNMY's 2025 results exceeded guidance: 6.2% revenue growth, 46% EBITDA margin, 10% dividend increase, and strong buybacks signal operational strength.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Acuity (NYSE: AYI - Get Free Report) and Edenred (OTCMKTS:EDNMY - Get Free Report) are both mid-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation and earnings. Volatility and Risk Acuity has a beta of
Edenred now trades at 8x P/E and offers a 7% dividend yield, presenting a compelling risk-reward profile despite regulatory headwinds. The business model is asset-light highly cash-generative and boasts a 20.84% net margin with €1,111 million in free cash flow for 2025. Edenred's core offering—tax-advantaged meal vouchers and gift cards—anchors it in markets with favorable tax laws, though this limits geographic expansion.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Edenred SE (EDNMY) Q4 2025 Earnings Call Transcript
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Edenred SE (OTC:EDNMY) Analyst/Investor Day November 4, 2025 8:00 AM EST Company Participants Bertrand Dumazy - Chairman & CEO Constance Le Bouar - Executive Vice President of Strategy, Marketing & Transformation Damien Perillat - Chief Operating Officer of Payment Solutions & New Markets Clément Le Chatelier Arnaud Erulin - Chief Operating Officer of Benefits & Engagement Diane Coliche - Chief Operating Officer of Mobility Virginie J. Duperat-Vergne - Executive Vice President of Finance Cedric Appert - Financial Communication & Investor Relations Director and Employee-Representative Director Conference Call Participants Edward Young - Morgan Stanley, Research Division Justin Forsythe - UBS Investment Bank, Research Division Sabrina Blanc - Sanford C.
Edenred SE (OTC:EDNMY) Q3 2025 Sales Call October 21, 2025 2:30 AM EDT Company Participants Virginie J. Duperat-Vergne - Executive Vice President of Finance Cedric Appert - Financial Communication & Investor Relations Director and Employee-Representative Director Conference Call Participants Andre Juillard - Deutsche Bank AG, Research Division Edward Young - Morgan Stanley, Research Division Josh Levin Julien Richer - Kepler Cheuvreux, Research Division Hannes Leitner - Jefferies LLC, Research Division Justin Forsythe - UBS Investment Bank, Research Division Kate Xiao - BofA Securities, Research Division Pravin Gondhale - Barclays Bank PLC, Research Division Estelle Weingrod - JPMorgan Chase & Co, Research Division Presentation Operator Welcome to the Edenred Q3 2025 Revenue Conference Call.